Business Context and Reporting Period
This Form 8-K Current Report was filed by Axe Compute Inc. (formerly Predictive Oncology Inc.) on December 10, 2025. The report covers events occurring on December 10, 2025, and December 12, 2025. The Company is incorporated in Delaware and its common stock trades on the NASDAQ Capital Market under the ticker symbol AGPU.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The report focuses exclusively on executive compensation amendments and corporate name changes.
Material Changes
- Executive Compensation: The Company amended the employment agreement of CEO Raymond F. Vennare, effective retroactively to November 1, 2025. His annual base salary increased from $525,000 to $575,000.
- Bonus Structure: Mr. Vennare is now eligible for an annual target bonus of 50% of his base salary, payable by March 31, 2026. Pro-rated bonus provisions apply in the event of termination without Cause or for Good Reason.
- Equity Grant: Mr. Vennare was granted 20,000 restricted stock units (RSUs) subject to the 2024 Equity Incentive Plan. These units vest in full on January 1, 2026, contingent on continuous employment.
- Corporate Identity: The Company officially changed its name from Predictive Oncology Inc. to Axe Compute Inc. Common stock began trading under the new ticker symbol AGPU on December 12, 2025.
Guidance, Outlook, and Risks
The filing contains no financial guidance, forward-looking outlook, or discussion of material risks and contingencies. The document is limited to the disclosure of the executive compensation amendment and the name change press release.
Investor Verification Checklist
- Verify the full text of the Employment Agreement Amendment (Exhibit 10.1) for specific definitions of "Cause" and "Good Reason."
- Confirm the trading status and ticker symbol change to AGPU on the NASDAQ Capital Market.
- Review the Company's 2024 Equity Incentive Plan to understand the terms governing the 20,000 RSU grant.
- Check subsequent filings for the first financial results under the new corporate name and ticker.